Skip to Content

J 58 (Lamivudine and zidovudine 150 mg / 300 mg)

This pill with imprint "J 58" is White, Capsule-shape and has been identified as Lamivudine and zidovudine 150 mg / 300 mg. It is manufactured by Aurobindo Pharma Limited.

Lamivudine/zidovudine is used in the treatment of occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Lamivudine/zidovudine 150 mg / 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lamivudine and zidovudine 150 mg / 300 mg J 58
Lamivudine and zidovudine 150 mg / 300 mg J 58 Front
Lamivudine and zidovudine 150 mg / 300 mg J 58 Back
Discount Card Promo
Lamivudine and zidovudine
J 58
150 mg / 300 mg
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Aurobindo Pharma Limited
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
hypromellose 2910 (6 mPa.s)
magnesium stearate
microcrystalline cellulose
polyethylene glycol 400
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0416 Amerisource Health Services

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.